This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

Overall, analysts have deemed the stock a “Strong Buy” with a mean target price of $231.25 which denotes upside potential of ...

An experimental once-daily pill appears to be effective at aiding weight loss and lowering blood sugar among people with type ...